Volume 19, Number 7—July 2013
CME ACTIVITY - Synopsis
Transmission of Streptococcus equi Subspecies zooepidemicus Infection from Horses to Humans
Table 1
Isolate (patient, source) | APIStrep† | STR Rapid ID32† | Agglutination with group serum specimens | VITEK2 GP-ID† | AccuProbe |
---|---|---|---|---|---|
Hum1 (patient 1, CSF) | 0063607 (99.9% S. zooepidemicus) | 15412061151 (99.9% S. zooepidemicus) | Group C | Not done | Not done |
Hum2 (patient 2, blood) | Not done | 15412061151 (99.9% S. zooepidemicus) | Group C | 053450364317451 (99% S. zooepidemicus) | Streptococcus agalactiae‡ |
Hum3 (patient 3, abdominal aortic wall) | Not done | 15512061111 (99.9% S. zooepidemicus) | Group C | Not done | Not done |
*ISLAB, Eastern Finland Laboratory Centre Joint authority Enterprise; CSF, cerebral spinal fluid.
†bioMérieux, Marcy l’Etoile, France.
‡S. agalactiae (315,588 reflective light units, the reference range below 50,000 reflective light units). S. agalactiae and S. zooepidemicus are known to cross-react in the AccuProbe Group B Streptococcus Culture ID Test (Gen-Probe, San Diego, CA, USA).
1These authors contributed equally to this article.
Page created: July 03, 2013
Page updated: July 03, 2013
Page reviewed: July 03, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.